Personalized antisense oligonucleotides 'for free, for life' - the n-Lorem Foundation

Nat Med. 2023 Jun;29(6):1302-1303. doi: 10.1038/s41591-023-02335-2.

Authors

Joseph G Gleeson^{1

2

3}, C Frank Bennett^{4

5}, Jeffrey B Carroll^{4

6}, Tracy Cole⁴, Julie Douville⁴, Sarah Glass⁴, Cedrik Tekendo-Ngongang⁴, Amy C Williford⁴, Stanley T Crooke⁴

Affiliations

¹ n-Lorem Foundation, Carlsbad, CA, USA. jogleeson@ucsd.edu.
² Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA. jogleeson@ucsd.edu.
³ Rady Children's Institute for Genomic Medicine, San Diego, CA, USA. jogleeson@ucsd.edu.
⁴ n-Lorem Foundation, Carlsbad, CA, USA.
⁵ Ionis Pharmaceutical, Carlsbad, CA, USA.
⁶ Department of Neurology, University of Washington, Seattle, WA, USA.

PMID: 37169866
DOI: 10.1038/s41591-023-02335-2

No abstract available

Publication types

Letter

MeSH terms

Oligonucleotides, Antisense* / therapeutic use

Substances

Oligonucleotides, Antisense